SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-082267
Filing Date
2023-03-28
Accepted
2023-03-28 16:45:03
Documents
14
Period of Report
2023-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d484008d8k.htm   iXBRL 8-K 24104
2 EX-99.1 d484008dex991.htm EX-99.1 84764
6 GRAPHIC g484008sp4.jpg GRAPHIC 2754
  Complete submission text file 0001193125-23-082267.txt   251240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vinc-20230328.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20230328_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20230328_pre.xml EX-101.PRE 11700
8 EXTRACTED XBRL INSTANCE DOCUMENT d484008d8k_htm.xml XML 3468
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 23770188
SIC: 2834 Pharmaceutical Preparations